Company intelligence / Profile preview

Kingswood Capital Partners

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Kingswood Capital Management is a private equity firm focused on middle-market investments, operational turnarounds, and carve-outs in several sectors including healthcare, but it is not a life sciences, biotech, or pharma company itself. It manages over $3.2 billion in assets and is active, with recent funds raised in 2024[2][6].

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnershipsmanaged 2024 IPO for WORK Medical Technology Group, a medical device company

Beyond the preview

Go deeper on Kingswood Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kingswood Capital Partners.

Explore the full profile